DIAMOND
A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of HF.
- Stage
- klaar
- Medicine
- Patiromer
- Population
- Hartfalen
- Phase
- IIIb
- First Patient In
- 9 October 2020
- Last Patient In
- 24 June 2021
- Last Patient Last Visit
- -
National Lead
dr. Brugts
Cardioloog
Study Director
